AllianceBernstein’s XBiotech XBIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-31,300
Closed -$270K 3394
2022
Q1
$270K Buy
31,300
+100
+0.3% +$1K ﹤0.01% 2904
2021
Q4
$347K Hold
31,200
﹤0.01% 2898
2021
Q3
$404K Hold
31,200
﹤0.01% 2841
2021
Q2
$517K Buy
31,200
+1,800
+6% +$30.5K ﹤0.01% 2794
2021
Q1
$505K Sell
29,400
-3,100
-10% -$57.9K ﹤0.01% 2656
2020
Q4
$509K Sell
32,500
-1,900
-6% -$35K ﹤0.01% 2580
2020
Q3
$657K Hold
34,400
﹤0.01% 2391
2020
Q2
$472K Hold
34,400
﹤0.01% 2649
2020
Q1
$365K Buy
34,400
+19,100
+125% +$311K ﹤0.01% 2515
2019
Q4
$286K Buy
15,300
+1,600
+12% +$20.6K ﹤0.01% 2796
2019
Q3
$143K Buy
+13,700
New +$112K ﹤0.01% 3016
2018
Q2
Sell
-42,700
Closed -$228K 3147
2018
Q1
$228K Hold
42,700
﹤0.01% 2798
2017
Q4
$168K Buy
42,700
+900
+2% +$3.79K ﹤0.01% 2906
2017
Q3
$183K Sell
41,800
-1,000
-2% -$4.72K ﹤0.01% 2965
2017
Q2
$201K Buy
42,800
+24,200
+130% +$232K ﹤0.01% 2994
2017
Q1
$307K Hold
18,600
﹤0.01% 2704
2016
Q4
$188K Hold
18,600
﹤0.01% 2905
2016
Q3
$250K Buy
18,600
+1,300
+8% +$19.1K ﹤0.01% 2764
2016
Q2
$362K Buy
+17,300
New +$250K ﹤0.01% 2632

Other funds holding XBIT

AllianceBernstein's XBIT Position: Q2 2022 in Review

AllianceBernstein sold out of XBiotech (XBIT) in Q2 2022, closing a stake of 31,300 shares — an estimated $270K sold.

AllianceBernstein first reported a position in XBIT in Q2 2016 and held it in 19 quarters. The position peaked at $657K in Q3 2020. 56 funds tracked by Wall St. Rank hold XBIT as of Q2 2022.

  • AllianceBernstein reported no remaining XBiotech position as of Q2 2022 after selling out during the quarter.
  • AllianceBernstein sold 31,300 XBiotech shares in Q2 2022, an estimated $270K.
  • AllianceBernstein first reported a position in XBiotech in Q2 2016 and held it in 19 quarters.
  • AllianceBernstein's XBiotech position peaked at $657K in Q3 2020.
  • 56 funds tracked by Wall St. Rank held XBiotech as of Q2 2022.

Based on AllianceBernstein's 13F filing for Q2 2022, filed 15 Aug 2022.